Earnings and revenue were both better than Wall Street expected. Analysts surveyed by Thomson First Call were looking for a top line of $591.8 million and a profit of 53 cents.Shares of Gilead were losing $1.16, or 2%, to $56.74 in after-hours trading. The stock fell $1.84, or 3.1%, in the regular session.
Gilead's Truvada Sales on Light Side
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts